THERAPEUTIC ADVANCES IN OPHTHALMOLOGY : Impact Factor & More
eISSN: 2515-8414pISSN: 2515-8414
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on THERAPEUTIC ADVANCES IN OPHTHALMOLOGY
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Vision UK |
| Frequency | Continuous publication |
| Publication Start Year | 2018 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 12 |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in THERAPEUTIC ADVANCES IN OPHTHALMOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in THERAPEUTIC ADVANCES IN OPHTHALMOLOGY
Challenges in myopia control strategies in the Middle East
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Evaluation of the effectiveness and safety of upadacitinib in the treatment of idiopathic refractory anterior scleritis: A case series study
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Effects of recurrent aflibercept and ranibizumab on intraocular pressure in diabetic retinopathy and age-related macular degeneration
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Higher recent dietary intake of total polyunsaturated fatty acids and vitamin E is associated with higher odds of neovascular age-related macular degeneration: a case-control study
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study
- 1 Sep 2026
- Therapeutic Advances in Ophthalmology
What thriving PhD students do differently lessons, habits, and reflections from the PhD journey
- 1 Sep 2026
- Therapeutic Advances in Ophthalmology
Challenges in myopia control strategies in the Middle East
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Evaluation of the effectiveness and safety of upadacitinib in the treatment of idiopathic refractory anterior scleritis: A case series study
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Effects of recurrent aflibercept and ranibizumab on intraocular pressure in diabetic retinopathy and age-related macular degeneration
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Higher recent dietary intake of total polyunsaturated fatty acids and vitamin E is associated with higher odds of neovascular age-related macular degeneration: a case-control study
- 1 Oct 2026
- Therapeutic Advances in Ophthalmology
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study
- 1 Sep 2026
- Therapeutic Advances in Ophthalmology
What thriving PhD students do differently lessons, habits, and reflections from the PhD journey
- 1 Sep 2026
- Therapeutic Advances in Ophthalmology
FAQs on THERAPEUTIC ADVANCES IN OPHTHALMOLOGY
How long has THERAPEUTIC ADVANCES IN OPHTHALMOLOGY been actively publishing? 
What is the publishing frequency of THERAPEUTIC ADVANCES IN OPHTHALMOLOGY?
How many articles did THERAPEUTIC ADVANCES IN OPHTHALMOLOGY publish last year?
What is the eISSN & pISSN for THERAPEUTIC ADVANCES IN OPHTHALMOLOGY?
Who is the publisher of THERAPEUTIC ADVANCES IN OPHTHALMOLOGY?
